For people with UC, ‘feeling better’ is just the start. Learn why tissue-level (histological) healing is becoming the new ...

ICOTYDE is the first and only IL-23R targeted oral peptide that delivers complete skin clearance and a favorable safety profile in a once-daily pill Approval supported by four phase 3 studies that met ...

The U.S. Food and Drug Administration has approved Johnson & Johnson's oral pill for psoriasis, ​the company said on ...

A team of scientists from the Indiana University School of Medicine has discovered a new link between an age-related blood condition and inflammatory bowel disease, often called IBD. Their research ...

Indiana University School of Medicine scientists have uncovered new evidence that an age-related blood condition may ...

IU researchers have linked an age-related blood condition to inflammatory bowel disease (IBD) and identified a potential treatment to reduce the severity of inflammation-driven diseases.

Mount Sinai and King Saud University Medical City in Riyadh, Saudi Arabia, today announced a three-year collaboration aimed at better understanding why inflammatory bowel disease (IBD) runs in some ...

T he goal of ulcerative colitis (UC) treatment is twofold: to heal the inflamed mucosal lining of the gut and to eliminate symptoms such as cramping and pain (usually once the inflammation subsides).

Pivotal Phase 3 global KEPLER study of vedolizumab intravenous (IV) in pediatric patients ages 2 to 17, who had an inadequate response to either conventional treatment options or tumor necrosis factor ...

SHANGHAI, Feb. 6, 2026 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and ...

Copyright: © 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies. The ASTRO double-blind ...